Stay updated on PembROlizuMab vs Chemo in MPM Clinical Trial

Sign up to get notified when there's something new on the PembROlizuMab vs Chemo in MPM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PembROlizuMab vs Chemo in MPM Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T12:59:22.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and Revision: v3.4.1 was removed. This appears to be a minor maintenance update with no impact on study details or user-visible information.
    Difference
    0.0%
    Check dated 2026-02-13T13:32:21.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Added the VANTAGE-014 publication reference (Lancet Oncology, 2015) and updated to revision v3.4.1 in the Publications section; removed the Lancet Oncology erratum and the prior revision (v3.4.0).
    Difference
    0.1%
    Check dated 2026-02-06T09:22:55.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    UI changes include Show glossary / Hide glossary controls, capitalization tweaks to labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and a new revision tag (Revision: v3.4.0) replacing v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-22T17:57:18.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.3.4, replacing Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T10:45:18.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    A citation for Vorinostat in mesothelioma was added to the Publications section and later removed, resulting in no net change to the study record. This change has no impact on the study's core information or accessible results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-08T06:27:10.000Z thumbnail image

Stay in the know with updates to PembROlizuMab vs Chemo in MPM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PembROlizuMab vs Chemo in MPM Clinical Trial page.